chr7-128850836-G-A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001458.5(FLNC):c.5432G>A(p.Arg1811Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,613,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1811W) has been classified as Uncertain significance.
Frequency
Consequence
NM_001458.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLNC | NM_001458.5 | c.5432G>A | p.Arg1811Gln | missense_variant | Exon 33 of 48 | ENST00000325888.13 | NP_001449.3 | |
FLNC | NM_001127487.2 | c.5333G>A | p.Arg1778Gln | missense_variant | Exon 32 of 47 | NP_001120959.1 | ||
FLNC-AS1 | NR_149055.1 | n.316-431C>T | intron_variant | Intron 3 of 3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152044Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000722 AC: 18AN: 249426 AF XY: 0.0000591 show subpopulations
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461612Hom.: 0 Cov.: 34 AF XY: 0.0000316 AC XY: 23AN XY: 727118 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000138 AC: 21AN: 152162Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74384 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26 Uncertain:1
- -
not provided Uncertain:1
Has not been previously published as pathogenic or benign to our knowledge; Observed in 0.0087% (24/277040) of global alleles in large population cohorts (Lek et al., 2016); Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 582215; Landrum et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function -
Cardiovascular phenotype Uncertain:1
The p.R1811Q variant (also known as c.5432G>A), located in coding exon 33 of the FLNC gene, results from a G to A substitution at nucleotide position 5432. The arginine at codon 1811 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at